Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

NCT06490003 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma
Chemotherapy Effect
DNA Methylation

Interventions

DRUG: Fluoro Uracil

Sponsor

City of Hope Medical Center